Showing 1 - 16 of 16 Items
Showing 1 - 16 of 16 Items
Sort By: Relevance
Journal Article
|Commentary
2025-05-01 • Lancet Global Health
2025-05-01 • Lancet Global Health
Journal Article
|Research
2025-03-06 • PLOS Global Public Health
2025-03-06 • PLOS Global Public Health
In 2021 in response to an outbreak of hepatitis E in Bentiu internally displaced persons camp the South Sudanese Ministry of Health with support from Médecins Sans Frontières implemen...
Journal Article
|Research
2025-01-08 • Lancet Infectious Diseases
2025-01-08 • Lancet Infectious Diseases
BACKGROUND
Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, particularly in Asia and Africa, where HEV genotypes 1 and 2 are prevalen...
Journal Article
|Research
2024-11-01 • Lancet Global Health
2024-11-01 • Lancet Global Health
Conference Material
|Slide Presentation
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
Conference Material
|Abstract
2024-05-16 • MSF Scientific Day International 2024
2024-05-16 • MSF Scientific Day International 2024
INTRODUCTION
Hepatitis E causes high mortality among pregnant women, with case fatality risks over 30% and adverse fetal outcomes. There is an evidence gap on the safety of the ...
Journal Article
|Research
2024-03-06 • PLOS Climate
2024-03-06 • PLOS Climate
This mixed-methods study focuses on the evidence of the health impacts of climate change on populations affected by humanitarian crises, presented from the perspective of Médecins Sans F...
Journal Article
|Research
2024-01-22 • PLOS Neglected Tropical Diseases
2024-01-22 • PLOS Neglected Tropical Diseases
INTRODUCTION
Hepatitis E (HEV) genotypes 1 and 2 are the common cause of jaundice and acute viral hepatitis that can cause large-scale outbreaks. HEV infection...
Conference Material
|Abstract
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
INTRODUCTION
A three-dose recombinant vaccine against hepatitis E, Hecolin, has been licensed for use in China since 2011. While not recommended for routine use due to lack of eviden...
A three-dose recombinant vaccine against hepatitis E, Hecolin, has been licensed for use in China since 2011. While not recommended for routine use due to lack of eviden...
Conference Material
|Poster
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Conference Material
|Slide Presentation
2023-06-07 • MSF Scientific Day International 2023
2023-06-07 • MSF Scientific Day International 2023
Journal Article
|Letter
2022-08-01 • Lancet Infectious Diseases
2022-08-01 • Lancet Infectious Diseases
Journal Article
|Short Report
2018-03-26 • Conflict and Health
2018-03-26 • Conflict and Health
The main causes of death during population movements can be prevented by addressing the population's basic needs. In 2013, the World Health Organization (WHO) issued a framework for deci...
Journal Article
|Research
2013-01-22 • Conflict and Health
2013-01-22 • Conflict and Health
Following a rapid influx of over 200,000 displaced Somalis into the Dadaab refugee camp complex in Kenya, Médecins Sans Frontières conducted a mortality and nutrition survey of the popul...
Journal Article
|Letter
2017-02-05 • Lancet Global Health
2017-02-05 • Lancet Global Health
Journal Article
|Research
2016-07-25 • American Journal of Tropical Medicine and Hygiene
2016-07-25 • American Journal of Tropical Medicine and Hygiene
Little is known about the residual effects of the west African Ebola virus disease (Ebola) epidemic on non-Ebola mortality and health-seeking behavior in Sierra Leone. We conducted a ret...